Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sodium thiosulfate for pruritus in maintenance hemodialysis patients
ChiCTR2200058021Phase 4Recruiting
- Sponsor
- Shanghai Sixth People's Hospital
- Start
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of sodium thiosulfate in chronic kidney disease-associated pruritus (CKD-aP) and uremia (3 arms), sponsored by Shanghai Sixth People's Hospital. Primary endpoints: Blood routine, Liver function and 4 more. Started Apr 2020; status: recruiting.
02
Drugs
sodium thiosulfate
03
Conditions
chronic kidney disease-associated pruritus (CKD-aP)uremia
Beyond the preview
Go deeper on ChiCTR2200058021.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200058021.